# FDA Inspection 786396 - DOW LAO Blood Bank - June 14, 2012

Source: https://www.keypedia.com/records/fda_inspections/dow-lao-blood-bank/094e52bc-2309-4ccd-bb52-0a3dfed79aac
Source feed: FDA_Inspections

> FDA Inspection 786396 for DOW LAO Blood Bank on June 14, 2012. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 786396
- Company Name: DOW LAO Blood Bank
- Inspection Date: 2012-06-14
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1211182 - 2023-07-12](https://www.keypedia.com/records/fda_inspections/dow-lao-blood-bank/5dee00e2-9c3a-4b4e-9e07-defb2d12908b)
- [FDA Inspection 1062223 - 2018-06-28](https://www.keypedia.com/records/fda_inspections/dow-lao-blood-bank/3c470ece-5fd9-4027-9c48-35187d097539)
- [FDA Inspection 967541 - 2016-04-07](https://www.keypedia.com/records/fda_inspections/dow-lao-blood-bank/05737720-de57-440a-8411-80e2f210c489)
- [FDA Inspection 871324 - 2014-03-25](https://www.keypedia.com/records/fda_inspections/dow-lao-blood-bank/baf1d45b-2e32-4028-977f-ce497e050180)
- [FDA Inspection 681928 - 2010-09-23](https://www.keypedia.com/records/fda_inspections/dow-lao-blood-bank/9f2cfc15-0473-4cf1-b7ba-ac20978ef3ed)

Company: https://www.keypedia.com/companies/dow-lao-blood-bank/52623460-27cd-456d-a1a6-37c211af6ebb

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d